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Acute respiratory infections are responsible for
high morbi–mortality in Peruvian children. How-
ever, the etiological agents are poorly identified.
This study, conducted during the pandemic out-
break of H1N1 influenza in 2009, aims to deter-
mine the main etiological agents responsible for
acute respiratory infections in children from
Lima, Peru. Nasopharyngeal swabs collected
from 717 children with acute respiratory infec-
tions between January 2009 and December 2010
were analyzed by multiplex RT-PCR for 13
respiratory viruses: influenza A, B, and C virus;
parainfluenza virus (PIV) 1, 2, 3, and 4; and
human respiratory syncytial virus (RSV) A and
B, among others. Samples were also tested with
direct fluorescent-antibodies (DFA) for six respi-
ratory viruses. RT-PCR and DFA detected respi-
ratory viruses in 240 (33.5%) and 85 (11.9%)
cases, respectively. The most common etiolog-
ical agents were RSV-A (15.3%), followed by
influenza A (4.6%), PIV-1 (3.6%), and PIV-2
(1.8%). The viruses identified by DFA corre-
sponded to RSV (5.9%) and influenza A (1.8%).
Therefore, respiratory syncytial viruses (RSV)
were found to be the most common etiology of
acute respiratory infections. The authors sug-
gest that active surveillance be conducted to
identify the causative agents and improve clin-
ical management, especially in the context
of possible circulation of pandemic viruses.
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INTRODUCTION
Acute respiratory infections are the leading cause
of pediatric morbidity and mortality worldwide
[Scheltinga et al., 2005; Grassi et al., 2014]. In Peru,
respiratory infections are a major healthcare prob-
lem, especially in children under 5 years of age, with
over 2.2 million infants being treated for this group
of infectious diseases annually. The most affected
areas are Lima East, Callao, Moquegua, Arequipa,
and Ucayali, where a cumulative incidence as high as
19,783, and eight episodes per 10,000 children, was
reported in 2013 [Gomez et al., 2013].
In 2009, Peru recorded one of the highest inciden-
ces of acute respiratory infections, with almost 2.8
million cases in children under 5 years of age [Gomez
et al., 2009]. In May that year, the first influenza A
(H1N1) case was confirmed. The pandemic rapidly
spread throughout the country and affected primarily
the 5–14 age group, with more than 80% of the cases
being reported in Lima [Munayco et al., 2009].
Surveillance of the pandemic in Peru provided val-
uable information about its behavior in a developing
southern hemisphere country, with over 8,000 con-
firmed cases until September 2009. This figure repre-
sents a 4% increase in acute respiratory infections
[Gomez et al., 2009]. However, information about
etiological agents of viral respiratory infections in
Peru is still limited. Active surveillance is therefore
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essential to identify the causative agents and improve
clinical management, especially in the context of
possible circulation of pandemic viruses [Schoub,
2006; Ren et al., 2009].
Many viruses, including influenza virus, parain-
fluenza virus (PIV), human respiratory syncytial
virus (RSV), human metapneumovirus (hMPV), hu-
man coronavirus (CoV), human rhinovirus (HRV),
adenovirus (ADV), and human enterovirus (HEV),
are known as common pathogens causing acute
respiratory infections in children [Gerna et al., 2006]
. Respiratory viruses can cause a wide spectrum of
illnesses in children, including pharyngitis, otitis
media, laryngitis, bronchitis, bronchiolitis, and
pneumonia. This broad presentation of viral respira-
tory infections makes it difficult to clinically identify
their etiology [Van Woensel et al., 2003]. Therefore,
a rapid, sensitive, and specific diagnosis tool is
essential for suitable therapeutic interventions
[Barenfanger et al., 2000].
Viral diagnosis of respiratory tract infections is
mainly done by direct antigen testing, virus isolation,
or nucleic acid amplification using polymerase chain
reaction (PCR). Viral culture and isolation is consid-
ered the gold standard, but this high-cost, elaborated
technique is usually performed for research purposes.
Antigen detection tests, such as direct fluorescent
antibody (DFA) test, are more commonly used be-
cause of their lower cost and rapid results, but often
lack sensitivity or specificity. Furthermore, these
tests produce false negatives in a high percentage of
cases [Bellau-Pujol et al., 2005]. Molecular techniques
have revolutionized the diagnosis of respiratory
viruses. Among them, PCR has shown to be the most
sensitive and specific in detection of respiratory
infectious agents, including samples with low copy
number [van Elden et al., 2002; Freymuth et al.,
2006; Van de Pol et al., 2007].
The aim of this study is to identify the etiological
agents responsible for acute respiratory infections in
children from January 2009 to December 2010 in
Lima, Peru. For this purpose, the study was con-
ducted according to the methodological guidance of
National Reference Center for Influenza (WHO
Centre for Influenza, National Center for Microbiol-
ogy, ISCIII, Spain). A total number of 13 and 6
viruses were detected by multiplex RT-PCR and
DFA, respectively.
MATERIALS AND METHODS
Patients
A group of 717 patients under 18 years old with
diagnosis of acute respiratory infection were recruited
from the Hospital Nacional Cayetano Heredia, Lima,
Peru, for prospective surveillance between Janu-
ary 2009 and December 2010. Epidemiological and
clinical features were registered on a database. Those
included age, symptoms (fever, defined as temperature
higher than 38˚C, rhinorrhea, cough, respiratory
difficulty, sore throat, wheezing, discomfort, pharyng-
eal congestion, expectoration, vomiting, diarrhea, etc.),
symptom duration, and time between sample taking
and arrival in laboratory.
This study was approved by the Research Ethics
Board of the Hospital Nacional Cayetano Heredia
and Instituto de Investigacion Nutricional (IIN). An
informed consent was signed by parents or children’s
caregivers before enrollment.
Samples
Two nasopharyngeal samples were obtained per
patient by inserting a swab into both nostrils parallel
to the palate (Mini-Tip Culture Direct, Becton-
Dickinson Microbiology System, MD) and a second
swab from the posterior pharyngeal and tonsillar
areas (Viral Culturette, Becton-Dickinson Microbiol-
ogy Systems). Both nasal and pharyngeal swabs were
placed into the same tube containing viral transport
medium (a minimal essential medium buffered with
NaHCO3 and supplemented with 2% fetal bovine
serum, penicillin and streptomycin 100U/ml, ampho-
tericin B 20mg/ml, neomycin 40mg/ml). Samples were
then stored at 4˚C until arrival in the laboratory of
molecular biology at the Universidad Peruana de
Ciencias Aplicadas (UPC)—Instituto de Investigacion
Nutricional (IIN). On receipt of the samples, the
swabs were discarded and the tubes were centrifuged
to pellet the cells, which were re-suspended in 1.5ml
of PBS (Phosphate Buffered Saline). Antigen detec-
tion was performed by direct immunofluorescence
assay (DFA), and two aliquots of each fresh specimen
were stored at 20˚C for reverse transcription PCR
(RT-PCR) analysis.
Immunofluorescence Detection
For direct immunofluorescence assay (DFA), samples
were stained with fluorescein-conjugated antibody for
influenza A and B virus, human parainfluenza virus
1–3 (hPIV1–3), adenovirus (ADV), and respiratory
syncytial virus (RSV) (Respiratory Panel 1, Viral
Screening and Identification Kit; Light Diagnostic,
CHEMICON International Temecula, USA). The pres-
ence of viral antigen in respiratory cells was indicated
by the appearance of characteristic intracellular green
fluorescence in1 cell.
Reverse Transcription Polymerase Chain
Reaction (RT-PCR)
For multiplex RT-PCR, viral genomic RNA and
DNA were extracted from a total volume of 200ml of
sample by the guanidinium thiocyanate extraction
method [Coiras et al., 2003]. The lysis buffer included
500 molecules of the cloned amplified product used as
internal control in each reaction tube and; false
negative results due to non-specific inhibitors or
extraction failure were discarded. Two independent
multiplex reverse transcription RT-PCR assays able
to detect from 1 to 10 copies of viral genomes were
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performed [Van Woensel et al., 2003; Coiras et al.,
2004]. One used specific primers for influenza A, B,
and C virus, respiratory syncytial virus (RSV-A and
RSV-B), and adenovirus (ADV); the other used spe-
cific primers for detection of human parainfluenza
virus (PIV-1, PIV-2, PIV-3, and PIV-4), coronavirus
(CoV-229E and CoV-OC43), human rhinovirus (HRV),
and enterovirus (HEV). Negative (viral transport
medium) and positive (cDNA viral) controls were
prepared by the same procedure for both tests.
Amplified products were recovered from the gel,
purified (SpinPrep Gel DNA Kit; San Diego, CA) and
sent for commercial sequencing (Macrogen, Korea).
Finally, viral etiology was determined when RT-PCR
and/or DFA samples were positive for at least one of
these viruses.
A viral etiology was considered, if RT-PCR and/or
DFA samples were positive for a respiratory virus.
Statistical Analysis
Quantitative variables were presented as an average
interquartile range (IQR) in two groups (virus infection
and viral co-infection). Qualitative variables were
reported as frequencies and percentages. Comparison
of proportions was determined by x2 or Fisher’s exact
test. Probability values of P< 0.05 were considered
significant. Analysis was performed using SPSS Sta-
tistics 20.0.0 software (IBM Corporation, NY).
RESULTS
The study was conducted on 717 patients under
18 years old with diagnosis of acute respiratory
infections between January 2009 and December 2010
in Lima, Peru. The most common age groups were
infants under 1 year old (60.2%) and 2–5 (21.6%),
followed by 6–10 (7.8%) and >10 (3.5%). Most were
hospitalized, 80.9% (580) whereas 19.1% (137) were
ambulatory patients. The most frequent symptoms
were fever (67.8%), rhinorrhea (61.4%), cough
(63.7%), and respiratory difficulty (54.1%) (Table I).
Regarding the 717 nasopharyngeal specimens
tested, the presence of at least one viral respiratory
pathogen was detected in 33.5% (240) of cases by
PCR and in only 11.9% (85) by DFA (Table II).
Human respiratory syncytial A (RSV-A) was the most
prevalent virus detected in 15.3% (110) by PCR,
followed by influenza A in 4.6% (33) and parain-
fluenza-1 (PIV-1) in 3.6% (26). Their probability of
occurrence (odds) was 18% for RSV-A, 4.8% for
influenza A and 3.8% for PIV-1. As for DFA detection,
the same pathogens were the most predominant, but
the human respiratory syncytial was detected in only
6.2% (42) of patients, influenza A in 1.8% (13) and
PIV-1 in 0.8% (6) (Table III). In addition, PCR
allowed the identification of viral co-infections. Thus,
a total of 13 cases of viral co-infections, with influ-
enza A and RSV-A being the most common pathogens
found in association with other respiratory viruses,
were reported (Table IV).
Respiratory viruses were analyzed according to age
distribution. The under 1-year-old group was the
most affected by viral infections, 44% (190/432),
followed by the under 10-year-old old group, 24% (6/
25), the 6–10 group, 23.2% (13/56), and the 2–5
group, 18.7% (29/155). Incidence of RSV-A was very
high in the 1-year old-group (21.8%) whereas inci-
dence of PIV-1 (4.6%), influenza A (4.4%), enterovirus
(3.5%), and PIV-2 (2.5%), among others, were low. On
the other hand, fewer cases of RSV-A were reported
in children aged 2–5, 6–10, and under 10 years old,
with an incidence of 6.5%, 5.4%, and 8%, respectively
(Table V).
Finally, a seasonal distribution of all respiratory
viruses detected between 2009 and 2010 was gener-
ally described (Fig. 1). Incidence of infections was
higher during autumn and early winter in both
TABLE I. Clinical Summary of Pediatric Patients With
Respiratory Disease
Number (%)
Children
Age (range years)
0–1 432 (60.2)
2–5 155 (21.6)
6–10 56 (7.8)
>10 25 (3.5)
NR* 49 (6.8)
Gender
Male 405 (56.5)
Women 285 (39.7)
NR* 27 (3.8)
Hospitalized 580 (80.9)
Ambulatory 137 (19.1)
Sample
Nasopharyngeal swab 706 (98.5)
Pharyngeal swab 8 (1.1)
Nasopharyngeal aspired 3 (0.4)
Clinical Symptoms
Fever 486 (67.8)
Cough 457 (63.7)
Rhinorrhea 440 (61.4)
Respiratory Difficulty 388 (54.1)
Sore Throat 121 (16.9)
Wheezing 255 (35.6)
Discomfort 52 (7.2)
Pharyngeal Congestion 173 (24.1)
Expectoration 165 (23.0)
Vomiting 87 (12.1)
Diarrhea 71 (9.9)
Others (<10% of cases): Ear pain, photophobia, conjunctival
congestion, abdominal pain, lymphadenopathy, fatigue,
headache, myalgia, skin rash.
Clinical Diagnosis
Viral Pneumonı´a 106 (14.8)
Viral Pharyngitis/Rhinopharyngitis 28 (3.9)
Bronchiolitis 56 (7.8)
Influenza Infection 47 (6.6)
Feverishness 30 (4.2)
EDA 7 (0.9)
Others (<2% of cases): Obstructive syndrome (bronchial,
bronchial acute), sinusitis, respiratory distress syndrome,
sepsis late atypical febrile seizure status epilepticus,
atypical febrile seizure, gastroenteritis.
*NR, not registered.
J. Med. Virol. DOI 10.1002/jmv
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years. The same distribution was reported for RSV-A,
with more than 50% of cases being detected during
the periods of May–June in 2009 and March–April in
2010. Similarly, all enterovirus cases were found
during May–June 2009. As for influenza A, one third
of cases were detected during June–July 2009
whereas in 2010, only four cases were found. On the
other hand, PIV-1 exhibited a constant rather than a
seasonal distribution.
DISCUSSION
Acute respiratory infections are a major public
health problem in children worldwide [Van Woensel
et al., 2003; Scheltinga et al., 2005; Grassi et al.,
2014], but most particularly in developing countries,
where it is estimated that over 1.5 million children
die every year, especially in the under 5-year-old age
group [Alonso et al., 2012; Kwon et al., 2014]. Our
study population was composed of 60.2% of infants
under 1 year old and 21.6% of children between 2–5
years old. The World Health Organization (WHO)
reports that, in Peru, less than 60% of these children
have access to an appropriate health care provider
[UNICEF, 2014; WHO, 2014].
Viruses can cause a broad spectrum of respiratory
illness in children. Etiological diagnosis of respiratory
viral infections remains a clinical and laboratory
challenge [Van de Pol et al., 2007; Alonso et al.,
2012]. A 2012 study conducted with children from
Rio de Janeiro, Brazil, with acute respiratory infec-
tions showed that the most frequent symptoms were
cough (54%), fever (53.6%), rhinorrhea (47.8%), and
nasal congestion (27.3%). Also, pneumonia was diag-
nosed in 24.4% of cases [Albuquerque et al., 2012].
The results of our study were similar since the most
common symptoms were fever (67.8%), cough (63.7%),
and rhinorrhea (61.4%). However, among 288 (40%)
patients with a specific clinical diagnosis, 106 (14.8%)
were diagnosed with pneumonia, probably because
most samples were from hospitalized children, 580
(80.9%) (Table I). In addition, viruses were mostly
identified in patients diagnosed with pneumonia,
63%, by far the major cause of respiratory-related
deaths [Alonso et al., 2012].
Appropriate viral etiology diagnosis in children
with acute respiratory infections is decisive to proper
care and treatment of this group of patients, as well
as to proper choice of preventive strategies [Bare-
nfanger et al., 2000; Van Woensel et al., 2003;
Nasreen et al., 2014]. Surveillance of influenza and
other respiratory infections is crucial to identifying
TABLE II. Comparison of the Diagnostic by PCR versus
IFD
Assay*
Cases (%) PCR IFD P-value**
Positive 240 (33.5) 85 (11.9) <0.001
Negative 477 (66.5) 599 (83.5) <0.001
Unspecific 0 (0.0) 33 (4.6)
Total 717 (100.0) 717 (100.0)
*x2-test, P< 0.001.
**z-test.
TABLE III. Prevalence of Pathogens Among Patients. Pathogens Agent Identified in the Diagnostic by PCR and IFD
PCR IFD
Pathogen Frequency Prevalence (%) Odds Frequency Prevalence (%) Odds
RSV — — — 42 5.9 0.062*
RSV-A 110 15.3 0.181* — — —
RSV-B 6 0.8 0.008 — — —
Influenza A 33 4.6 0.048 13 1.8 0.018
Influenza B 5 0.7 0.007 4 0.6 0.006
Influenza C 1 0.1 0.001 — — —
Adenovirus 1 0.1 0.001 1 0.1 0.001
Rhinovirus 5 0.7 0.007 — — —
Coronavirus 8 1.1 0.011 — — —
Parainfluenza-1 26 3.6 0.038 6 0.8 0.008
Parainfluenza-2 13 1.8 0.018 5 0.7 0.007
Parainfluenza-3 7 1.0 0.010 1 0.1 0.001
Parainfluenza-4 7 1.0 0.010 — — —
Enterovirus 18 2.5 0.026 — — —
*z-test, P< 0.05.
TABLE IV. Viral Co-Infections
Pathogens: Virus-Virus Cases (%)
Influenza A & RSV-A 1 (0.14)
Influenza A & Rhinovirus 1 (0.14)
Influenza A & RSV-B 2 (0.28)
Influenza A & Parainfluenza-2 1 (0.14)
RSV-A & Adenovirus 1 (0.14)
RSV-A & Enterovirus 2 (0.28)
RSV-A & Parainfluenza-1 3 (0.41)
RSV-A & Parainfluenza-2 1 (0.14)
Parainfluenza-1 & Enterovirus 1 (0.14)
Total cases 13 (1.81)
*z-test, P< 0.05.
J. Med. Virol. DOI 10.1002/jmv
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the distribution, trend and impact of viruses circulat-
ing in a population, even in non-pandemic periods
[Watanabe et al., 2011; Zhao et al., 2014]. Using
routinely available hospital laboratory data at mini-
mum extra cost is an important addition to the
current respiratory virus surveillance system [Zhao
et al., 2014].
Polymerase Chain Reaction (PCR) is a highly
sensitive, specific method for the detection of a broad
spectrum of respiratory viruses [van Elden et al.,
2002; Mahony et al., 2007; Lamara˜o et al., 2012].
Compared to conventional diagnostic tests, like Direct
Immunofluorescence Assay (DFA), PCR increases
diagnostic yields of respiratory virus detection from
24% to 43% of cases [Turner et al., 2013]. Therefore,
PCR is the laboratory surveillance method of choice
[Barenfanger et al., 2000; van Elden et al., 2002;
Mahony et al., 2007; Van de Pol et al., 2007; Zhao
et al., 2014]. The above figures are consistent with
our study results, which show that respiratory viral
detection increases from 11.9%, by DFA to 33.5%, by
PCR (Table II). However, limited data are available
regarding clinical presentation and strains of these
viruses in Latin America [Sovero et al., 2011; Garcia
et al., 2013; Turner et al., 2013; Grassi et al., 2014].
The prevalence of these pathogens is underestimated
due to lack of rapid and proper virus identification
tools in many areas [Alonso et al., 2012]. In Peru,
respiratory virus surveillance has been conducted in
28 hospitals around the country since 2012. Samples
of acute respiratory infection patients are analyzed
by DFA and only influenza positive cases are sub-
jected to PCR detection [Tejada, 2013]. Furthermore,
collected data remain unpublished and few studies
have been undertaken about circulating respiratory
viruses in the last 5 years, especially concerning
specific viral etiology detection (although a few more
on viral surveillance can be found) [Forshey et al.,
TABLE V. Virus Distribution According to Age Range
Age Range (years)
Pathogens 0–1 (n¼ 432) 2–5 (n¼ 155) 6–10 (n¼56) >10 (n¼ 25) *NR (n¼49) Total patients (n¼717)
RSV-A 94 (21.8%) 10 (6.5%) 3 (5.4%) 2 (8.0%) 1 (2.0%) 110 (15.3%)
RSV-B 6 (1.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 6 (0.8%)
Influenza A 19 (4.4%) 6 (3.9%) 4 (7.1%) 4 (16%) 0 (0.0%) 33 (4.6%)
Influenza B 3 (0.7%) 0 (0.0%) 2 (3.6%) 0 (0.0%) 0 (0.0%) 5 (0.7%)
Influenza C 1 (0.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%)
Adenovirus 1 (0.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%)
Rhinovirus 4 (0.9%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 5 (0.7%)
Coronavirus 5 (1.2%) 3 (1.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 8 (1.1%)
Parainfluenza-1 20 (4.6%) 3 (1.9%) 3 (5.4%) 0 (0.0%) 0 (0.0%) 26 (3.6%)
Parainfluenza -2 11 (2.5%) 0 (0.0%) 1 (1.8%) 0 (0.0%) 1 (2.0%) 13 (1.8%)
Parainfluenza -3 7 (1.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 7 (1.0%)
Parainfluenza -4 4 (0.9%) 3 (1.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 7 (1.0%)
Enterovirus 15 (3.5%) 3 (1.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 18 (2.5%)
Total cases positives 190 (44.0%) 29 (18.7%) 13 (23.2%) 6 (24%) 2 (4.1%) 240 (33.5%)
*NR, not registered.
Fig. 1. Respiratory virus seasonal distribution (2009–2010).
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2010; Padilla-Ygreda et al., 2010; Salmon-Mulanovich
et al., 2011; Budge et al., 2014a].
A household-based study conducted in high-altitude
rural Peruvian settings reported an adjusted inci-
dence of 6.2 respiratory infection/child-year, and the
virus-specific incidences per 100 child-years were
rhinovirus, 236; adenovirus, 73; parainfluenza, 46;
influenza, 37; respiratory syncytial virus, 30; and
human metapneumovirus, 17 [Budge et al., 2014b].
In our study, human respiratory syncytial virus A
(RSV-A) was the most prevalent virus in 15.3% of
patients (110), followed by influenza A in 4.6% (33)
and parainfluenza-1 (PIV-1) in 3.6% (26) (Table III).
This was probably due to differences in respiratory
virus circulation patterns among the regions and the
large number of hospitalized patients in our study
population.
Respiratory syncytial virus (RSV) has frequently
been identified as the most common viral etiology in
infants with respiratory infections [Van Woensel
et al., 2003; Turner et al., 2013]. Incidence rates as
high as 53.2% are typically reported for RSV, a virus
strongly associated with severe respiratory infec-
tions, including pneumonia [Alonso et al., 2012;
Lamara˜o et al., 2012; Garcia et al., 2013; Tejada,
2013; Turner et al., 2013; Kwon et al., 2014; Zhao
et al., 2014]. In the present study, RSV was also the
predominant viral etiology (42%), with a very high
incidence in under 1-year-old infants (21.8%),
whereas lower incidences were found in other age
groups (Table V).
A study performed in Ecuador described that
influenza viruses may be the second most common
cause of acute respiratory infections in childhood
[Alonso et al., 2012]. Another finding was that
influenza viruses are more likely to be detected in
under 5-year-old patients, with an incidence of 9.4–
9.6% in the last 2 years [Watanabe et al., 2011;
Turner et al., 2013; Kwon et al., 2014]. Nonetheless,
a recent work showed that infants and young chil-
dren have a 12-fold increased risk of admission to
hospital for respiratory tract infection caused by
influenza virus compared with children aged 5–17
years [Van Woensel et al., 2003]. Influenza virus was
also the second most frequent etiology detected in our
samples: influenza A in 4.6% and influenza B and C
in only 0.7% and 0.1%, respectively (Table V). Influ-
enza A was more common in children under 10 years
old, with 16% of cases. However, an influenza H1N1v
outbreak occurred during our study period, which
may explain an abrupt increase in Influenza A cases
during June to September in 2009.
Co-infection with other respiratory viruses was
not rare and was described in 2.9–8% of samples
[Mahony et al., 2007; Sovero et al., 2011; Watanabe
et al., 2011; Alonso et al., 2012; Lamara˜o et al.,
2012]. The most common co-infections (67%) were
RSV co-occurrences with other viruses, chiefly influ-
enza A, followed by parainfluenza-3, adenovirus, and
hMPV [Mahony et al., 2007; Alonso et al., 2012].
Other influenza A virus co-infections have also been
reported, especially with rhinovirus, parainfluenza
virus, and hMPV [Mahony et al., 2007]. These data
are compatible with our results, 13 cases of co-
infection of influenza A and RSV-A, the most
common pathogens associated with parainfluenza,
rhinovirus, adenovirus, and enterovirus (Table IV).
Although most respiratory viral infections occur
throughout the year, seasonal variation in a compa-
rable pattern is obvious for certain viruses, such as
respiratory syncytial virus, influenza virus and para-
influenza virus [Van Woensel et al., 2003; Watanabe
et al., 2011; Alonso et al., 2012; Lamara˜o et al., 2012;
Zhao et al., 2014]. On the contrary, no clear seasonal
patterns have been described for adenovirus and
rhinovirus, not even after long periods of study
[Alonso et al., 2012; Ampuero et al., 2012; Zhao et al.,
2014].
In the present study, a higher incidence of respira-
tory viral infections was observed during autumn and
early winter in both years. Nevertheless, to establish
seasonality for respiratory viruses can be challenging.
A study aimed to provide epidemiologic information
about human parainfluenza viruses in Latin Ameri-
can cities between 2006 and 2010 revealed differences
in patterns depending on the climate, altitude, and
latitude. Particularly, in Piura (Peru) PIV-1 showed
several primary peaks between June and July. How-
ever, comparison of PIV-1 incidence between Piura
(Peru) and Fortaleza (Brazil), located at only 2˚N,
showed differences in distribution, suggesting that
seasonality may be associated with temperature
rather than distance from the Equator [Villaran
et al., 2014]. In contrast, a constant, rather than
seasonal, incidence was observed for PIV-1 in the
Lima study whereas a higher incidence was reported
during autumn for RSV-A, with more than 50% of
cases detected, especially during May–June in 2009
and March–April in 2010. A similar seasonal distri-
bution had been reported in Brazil, Argentina, and
Chile [Luchsinger et al., 2008; Vidaurreta et al.,
2011; Albuquerque et al., 2012].
In conclusion, respiratory virus surveillance pro-
grams are essential in Peru, just like in other Latin
American countries, since they would prevent inap-
propriate antibiotic prescription and resistance to
other viral etiologies accounting for increased health
care demands and hospitalizations.
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